The Efficancy and Tolerance of Tacrolimus Sustained-release Capsules in Induction Treatment in Lupus Nephritis.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Tacrolimus (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 05 Jul 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 09 Feb 2011 New trial record